0,818  0,003  Sulfotransferase substrate
0,778  0,004  NOS3 expression inhibitor
0,776  0,003  P-glycoprotein inhibitor
0,726  0,004  Superoxide dismutase inhibitor
0,711  0,006  CTGF expression inhibitor
0,677  0,004  Antiseptic
0,679  0,014  GST A substrate
0,648  0,003  Neurotrophic factor enhancer
0,645  0,004  Skin whitener
0,635  0,003  SULT1A3 substrate
0,635  0,003  Tyrosine 3 hydroxylase inhibitor
0,645  0,014  Respiratory analeptic
0,643  0,019  TNF expression inhibitor
0,619  0,011  CYP2D6 substrate
0,612  0,005  Monophenol monooxygenase inhibitor
0,609  0,008  Free radical scavenger
0,606  0,008  Amyloid beta aggregation inhibitor
0,606  0,011  Antioxidant
0,584  0,009  Cardiodepressant
0,574  0,012  NOS2 expression inhibitor
0,572  0,013  Histamine release inhibitor
0,569  0,012  Lipoxygenase inhibitor
0,557  0,003  Cystathionine beta-synthase inhibitor
0,554  0,009  UDP-glucuronosyltransferase substrate
0,560  0,017  Analeptic
0,560  0,017  5 Hydroxytryptamine release inhibitor
0,563  0,024  Aldehyde oxidase inhibitor
0,552  0,017  12-Lipoxygenase inhibitor
0,552  0,020  5 Hydroxytryptamine release stimulant
0,546  0,016  UGT1A9 substrate
0,538  0,009  Antimutagenic
0,557  0,031  15-Lipoxygenase inhibitor
0,530  0,017  Cardiovascular analeptic
0,533  0,024  Antipruritic, allergic
0,529  0,020  CYP1A2 substrate
0,512  0,005  Breast cancer-resistant protein inhibitor
0,516  0,010  Antihypertriglyceridemic
0,506  0,005  VCAM1 expression inhibitor
0,535  0,035  CYP3A4 substrate
0,536  0,039  Transcription factor NF kappa B inhibitor
0,509  0,014  Hypoglycemic
0,498  0,006  Amylase inhibitor
0,548  0,061  Apoptosis agonist
0,509  0,023  GABA C receptor rho-3 antagonist
0,490  0,014  ICAM1 expression inhibitor
0,476  0,015  UGT2B4 substrate
0,461  0,006  5 Hydroxytryptamine uptake stimulant
0,465  0,013  Peroxidase inhibitor
0,487  0,035  Cholesterol antagonist
0,470  0,020  Vasodilator, coronary
0,474  0,027  Spasmolytic
0,479  0,036  Calcium channel L-type activator
0,464  0,021  Antiprotozoal (Leishmania)
0,459  0,019  Antipyretic
0,469  0,030  Antihypercholesterolemic
0,493  0,063  Caspase 9 stimulant
0,445  0,023  Proliferative diseases treatment
0,440  0,019  UGT1A6 substrate
0,447  0,029  Radioprotector
0,422  0,010  Melanin inhibitor
0,429  0,018  Eye irritation, high
0,436  0,031  AR expression inhibitor
0,410  0,006  Acetylcholinesterase inhibitor
0,463  0,062  Antidiabetic
0,463  0,062  Cyclophilin D inhibitor
0,411  0,017  Transcription factor STAT inhibitor
0,438  0,044  CYP2C19 inhibitor
0,408  0,016  FMO3 substrate
0,428  0,036  Caspase 3 stimulant
0,421  0,031  Chemoprotective
0,391  0,003  SULT1A1 substrate
0,398  0,009  Pneumotoxic
0,413  0,027  Hypoxia-inducible factor 1 alpha inhibitor
0,412  0,027  Chemopreventive
0,480  0,096  Antiinflammatory
0,421  0,038  CYP2C19 substrate
0,399  0,017  Flavin-containing monooxygenase substrate
0,388  0,011  Genotoxic
0,419  0,044  Bone diseases treatment
0,427  0,054  CYP2C9 substrate
0,398  0,033  Sensitization
0,388  0,025  Vasodilator
0,384  0,022  Sodium/bile acid cotransporter inhibitor
0,381  0,019  Antiarrhythmic
0,361  0,007  Phospholipase A2 inhibitor
0,376  0,024  Transcription factor STAT3 inhibitor
0,397  0,046  FMO1 substrate
0,411  0,060  Antileukemic
0,404  0,054  Vasodilator, peripheral
0,350  0,007  5-Lipoxygenase inhibitor
0,350  0,009  Antihelmintic (Nematodes)
0,332  0,003  HIV-1 integrase (Overall Integration) inhibitor
0,351  0,022  UGT1A4 substrate
0,358  0,031  Nitric oxide antagonist
0,350  0,023  GST M1-1 substrate
0,339  0,013  UGT2B15 substrate
0,337  0,014  Lipid peroxidase inhibitor
0,348  0,026  Wound healing agent
0,336  0,014  Cholinergic
0,325  0,005  Farnesoid X receptor antagonist
0,345  0,026  Abortion inducer
0,381  0,064  Stroke treatment
0,320  0,007  Interleukin 4 antagonist
0,343  0,031  Antiulcerative
0,351  0,039  Antihypoxic
0,347  0,040  Antiamyloidogenic
0,325  0,018  UGT1A3 substrate
0,331  0,026  UGT1A1 substrate
0,352  0,049  Antiosteoporotic
0,305  0,003  DOPA decarboxylase inhibitor
0,308  0,006  Estrogen antagonist
0,353  0,051  Lipoprotein disorders treatment
0,319  0,017  Hair growth stimulant
0,325  0,023  Antihypotensive
0,369  0,072  CYP2C9 inhibitor
0,381  0,085  Antibacterial
0,306  0,010  Succinate dehydrogenase inhibitor
0,340  0,045  CYP1A2 inhibitor
0,333  0,039  Pyruvate kinase inhibitor
0,313  0,019  MAO inhibitor
0,336  0,044  Cytostatic
0,351  0,061  Streptokinase A inhibitor
0,292  0,002  SULT1A2 substrate
0,364  0,076  Ulceration
0,344  0,058  Apoptosis antagonist
0,295  0,010  Antifungal enhancer
0,327  0,043  Insulysin inhibitor
0,299  0,018  Phospholipase C inhibitor
0,299  0,019  Protein-tyrosine phosphatase inhibitor
0,284  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,358  0,083  Immunosuppressant
0,280  0,005  Estrogen receptor beta antagonist
0,304  0,031  RNA-directed DNA polymerase inhibitor
0,274  0,006  Porphobilinogen synthase inhibitor
0,280  0,013  Carcinogenic, group 1
0,331  0,064  Calcium channel activator
0,289  0,024  Antipruritic, non-allergic
0,283  0,020  Insulin sensitizer
0,276  0,017  MAO A inhibitor
0,267  0,009  UGT2B1 substrate
0,319  0,063  CYP2D6 inhibitor
0,304  0,048  Angiogenesis stimulant
0,315  0,061  Antineoplastic (small cell lung cancer)
0,306  0,052  Radiosensitizer
0,313  0,065  Cardioprotectant
0,270  0,021  Nitric-oxide synthase stimulant
0,277  0,031  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,371  0,127  Alpha-glucosidase inhibitor
0,252  0,009  Histidine decarboxylase inhibitor
0,304  0,061  Teratogen
0,300  0,056  Cardiotonic
0,258  0,015  Chelator
0,272  0,034  Dual specificity phosphatase 3 inhibitor
0,279  0,042  Calpain inhibitor
0,250  0,013  UGT2B10 substrate
0,242  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,252  0,016  Protein-tyrosine phosphatase 1B inhibitor
0,252  0,017  Cholesterol synthesis inhibitor
0,272  0,038  Growth hormone agonist
0,239  0,006  Creatine kinase inhibitor
0,335  0,103  Antineoplastic (breast cancer)
0,245  0,014  GABA C receptor agonist
0,251  0,021  GST P1-1 substrate
0,264  0,035  Dual specificity phosphatase inhibitor
0,264  0,036  UGT2B7 substrate
0,269  0,042  Anesthetic general
0,326  0,099  Calpain 2 inhibitor
0,252  0,026  Protein kinase stimulant
0,287  0,062  Embryotoxic
0,251  0,027  Antiischemic, cerebral
0,243  0,022  UGT2B9 substrate
0,237  0,019  VEGF expression inhibitor
0,229  0,012  Choleretic
0,259  0,044  DNA methylase inhibitor
0,243  0,030  Interferon gamma antagonist
0,298  0,086  Prostate cancer treatment
0,223  0,011  Dementia treatment
0,256  0,044  DNA methyltransferase I inhibitor
0,221  0,011  Potassium channel (Ca-activated) activator
0,214  0,006  Glutamate decarboxylase inhibitor
0,246  0,040  Antiviral (West Nile virus)
0,216  0,011  Vascular dementia treatment
0,211  0,008  Sphingosine 1-phosphate receptor 5 antagonist
0,217  0,014  CF transmembrane conductance regulator agonist
0,209  0,009  Papain-like protease (SARS coronavirus) inhibitor
0,208  0,007  Macrophage migration inhibitory factor inhibitor
0,221  0,022  Glutathione S-transferase substrate
0,217  0,019  Arachidonic acid antagonist
0,265  0,068  Tumour necrosis factor alpha release inhibitor
0,231  0,034  Heat shock protein 90 alpha antagonist
0,214  0,016  UDP-glucose 4-epimerase inhibitor
0,261  0,064  Antiglaucomic
0,239  0,043  CYP2B6 inhibitor
0,212  0,017  Carbonic anhydrase XV inhibitor
0,264  0,069  Interleukin agonist
0,223  0,028  Alpha-N-acetylglucosaminidase inhibitor
0,292  0,098  Thyroid hormone antagonist
0,253  0,060  Interleukin antagonist
0,230  0,038  Acaricide
0,219  0,027  Anesthetic local
0,197  0,007  Phenylalanine 4-hydroxylase inhibitor
0,201  0,012  Vanilloid 1 agonist
0,308  0,119  Antiprotozoal
0,279  0,090  Interleukin 2 agonist
0,210  0,023  MAO B inhibitor
0,202  0,016  Carbonic anhydrase III inhibitor
0,199  0,013  Photosensitizer
0,201  0,015  Antihelmintic (Trematoda)
0,293  0,107  Thioredoxin glutathione reductase inhibitor
0,235  0,050  Antihelmintic
0,220  0,038  LDLR expression enhancer
0,245  0,063  Antiparasitic
0,202  0,021  Antihemorrhagic
0,185  0,007  Leukotriene antagonist
0,211  0,032  Antineoplastic (bone cancer)
0,182  0,005  Bile acid receptor antagonist
0,228  0,051  Hepatoprotectant
0,246  0,069  Hypolipemic
0,200  0,023  Toll-Like receptor 2 antagonist
0,253  0,077  Antineoplastic (renal cancer)
0,189  0,014  Alcohol dehydrogenase inhibitor
0,182  0,006  Leukotriene synthesis inhibitor
0,192  0,018  Coagulant
0,194  0,021  Xanthine oxidase inhibitor
0,195  0,022  Excitatory amino acid transporter EAAC1 inhibitor
0,207  0,035  Heat shock protein 90 antagonist
0,200  0,028  Neurotrophic factor
0,196  0,023  Ferrochelatase inhibitor
0,188  0,018  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,180  0,011  HIV-1 integrase (3'-Processing) inhibitor
0,209  0,040  Prostate disorders treatment
0,188  0,020  Adenylate cyclase stimulant
0,267  0,099  Antifungal
0,201  0,034  Cyclooxygenase 1 inhibitor
0,183  0,016  Carbonic anhydrase XIII inhibitor
0,177  0,011  Transcription factor STAT6 inhibitor
0,222  0,056  Non-steroidal antiinflammatory agent
0,180  0,014  Sphingosine 1-phosphate receptor 4 antagonist
0,180  0,015  Sphingosine 1-phosphate receptor 2 antagonist
0,194  0,030  DNA polymerase I inhibitor
0,201  0,037  Antirickettsial
0,188  0,025  Movement disorders treatment
0,202  0,039  Anesthetic
0,179  0,016  TRPA1 agonist
0,171  0,008  UGT2B11 substrate
0,184  0,022  Growth stimulant
0,233  0,072  Cyclic AMP phosphodiesterase inhibitor
0,267  0,107  Thyroid hormone beta antagonist
0,201  0,042  Toxic, respiratory center
0,169  0,011  SULT1E1 substrate
0,222  0,063  Carcinogenic
0,306  0,148  Antiarthritic
0,168  0,010  Estrogen agonist
0,172  0,015  Prolactin inhibitor
0,187  0,031  Aldehyde dehydrogenase inhibitor
0,192  0,036  Skin irritative effect
0,180  0,024  Falcipain 3 inhibitor
0,193  0,038  Catenin beta inhibitor
0,185  0,031  Antihyperlipoproteinemic
0,166  0,012  Keratolytic
0,242  0,089  Gastrin inhibitor
0,159  0,007  HIV-1 integrase inhibitor
0,188  0,036  GABA C receptor rho-2 antagonist
0,167  0,015  Ca2+-transporting ATPase inhibitor
0,240  0,089  Antiprotozoal (Trypanosoma)
0,191  0,040  Neurotensin receptor agonist
0,212  0,064  Mutagenic
0,180  0,032  Proteasome inhibitor
0,153  0,005  Estrogen receptor alpha agonist
0,189  0,041  Antidiarrheal
0,202  0,055  Mcl-1 antagonist
0,154  0,007  Estrogen receptor beta agonist
0,157  0,011  Estrogen receptor alpha antagonist
0,151  0,005  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,157  0,015  Antifungal (Pneumocystis)
0,180  0,038  Cocaine dependence treatment
0,171  0,030  Carcinogenic, group 2B
0,161  0,020  Beta glucuronidase inhibitor
0,215  0,076  Antiparkinsonian, rigidity relieving
0,186  0,048  Uterine stimulant
0,144  0,007  Anticholelithogenic
0,142  0,005  Leukotriene D4 antagonist
0,257  0,121  Antithrombotic
0,152  0,017  Anabolic
0,143  0,009  GABA aminotransferase inhibitor
0,155  0,021  Antispirochetal
0,183  0,049  NOS3 expression enhancer
0,144  0,011  Alcohol oxidase inhibitor
0,148  0,016  Paget's disease treatment
0,137  0,005  Estrogen-related receptor beta agonist
0,142  0,011  Lipase inhibitor
0,159  0,028  NAT2 substrate
0,139  0,008  Purinergic P2X1 antagonist
0,222  0,092  DNA synthesis inhibitor
0,179  0,051  Antidote
0,170  0,043  M18 aspartyl aminopeptidase inhibitor
0,151  0,025  Chronic obstructive bronchitis treatment
0,157  0,031  Butyrylcholinesterase inhibitor
0,132  0,006  Leukotriene B4 antagonist
0,142  0,017  Histamine N-methyltransferase inhibitor
0,158  0,034  Aminopeptidase B inhibitor
0,139  0,015  Ornithine decarboxylase inhibitor
0,156  0,032  Gastritis treatment
0,128  0,005  Potassium channel Kv1.3 blocker
0,151  0,028  Antihelmintic (Fasciola)
0,140  0,017  Antidote, mercury
0,142  0,020  Phosphofructokinase-1 inhibitor
0,200  0,078  Cytotoxic
0,227  0,106  Antineoplastic (melanoma)
0,130  0,009  Narcotic antagonist
0,172  0,051  CNS active muscle relaxant
0,149  0,029  Aldehyde dehydrogenase substrate
0,155  0,035  Heat shock protein 70 antagonist
0,160  0,040  Cyclooxygenase 3 inhibitor
0,123  0,004  SULT2A1 substrate
0,169  0,050  Mannose-6-phosphate isomerase inhibitor
0,134  0,015  CDC25A inhibitor
0,134  0,016  Glutathione S-transferase inhibitor
0,134  0,020  Adrenaline agonist
0,146  0,032  GABA C receptor antagonist
0,125  0,011  D-Ala-D-Ala ligase inhibitor
0,121  0,008  Endocannabinoid uptake inhibitor
0,208  0,096  Antineoplastic (cervical cancer)
0,165  0,054  Antiacne
0,117  0,008  GABA B receptor agonist
0,166  0,059  Cyclooxygenase inhibitor
0,200  0,093  Antiviral (HIV)
0,132  0,027  Topoisomerase II alpha inhibitor
0,116  0,011  Beta 3 adrenoreceptor antagonist
0,141  0,038  Mucolytic
0,152  0,048  Antiprotozoal (Trichomonas)
0,122  0,019  Aminopeptidase I inhibitor
0,108  0,006  Sphingosine 1-phosphate receptor 3 agonist
0,114  0,012  Beta adrenoreceptor antagonist
0,131  0,029  GST T1-1 substrate
0,137  0,035  Mediator release inhibitor
0,110  0,009  Estradiol 17 beta-dehydrogenase inhibitor
0,120  0,020  Peroxisome proliferator-activated receptor gamma agonist
0,112  0,013  CDC25B inhibitor
0,127  0,028  Triose-phosphate isomerase inhibitor
0,148  0,051  Topoisomerase II inhibitor
0,153  0,056  Bone formation stimulant
0,101  0,004  Dopamine D5 agonist
0,142  0,046  Interleukin 1b antagonist
0,129  0,033  GABA C receptor rho-1 antagonist
0,123  0,027  Phosphodiesterase 4D inhibitor
0,111  0,016  Aldose reductase inhibitor
0,104  0,010  Prostaglandin F2 alpha antagonist
0,101  0,008  Sphingosine 1-phosphate receptor 3 antagonist
0,218  0,125  Antineoplastic (multiple myeloma)
0,207  0,116  Immunostimulant
0,123  0,034  NMDA receptor antagonist
0,108  0,020  Amidase inhibitor
0,090  0,004  Thyroid hormone alpha antagonist
0,151  0,065  Antiparkinsonian, tremor relieving
0,101  0,016  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,143  0,059  NADPH oxidase inhibitor
0,108  0,025  Vanilloid agonist
0,146  0,063  Alkaline phosphatase inhibitor
0,224  0,142  Prostaglandin dehydrogenase inhibitor
0,098  0,016  Xanthine dehydrogenase inhibitor
0,108  0,027  Myeloperoxidase inhibitor
0,177  0,095  Psychostimulant
0,096  0,014  Antimycoplasmal
0,093  0,013  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,086  0,006  Leukotriene C antagonist
0,112  0,033  Carbonic anhydrase VI inhibitor
0,091  0,012  Beta 1 adrenoreceptor antagonist
0,100  0,022  CC chemokine 5 receptor agonist
0,084  0,007  Beta 2 adrenoreceptor agonist
0,133  0,057  Antineoplastic (uterine cancer)
0,130  0,054  Contraceptive female
0,098  0,022  Glycine receptor agonist
0,150  0,074  Acetylcholine M1 receptor antagonist
0,152  0,077  Hexokinase inhibitor
0,086  0,012  Sphingosine kinase inhibitor
0,092  0,020  Maillard reaction inhibitor
0,085  0,013  Sphingosine kinase 2 inhibitor
0,087  0,015  Peroxisome proliferator-activated receptor alpha agonist
0,111  0,039  Arylamine N-Acetyltransferase substrate
0,076  0,004  Leukotriene B4 receptor 1 antagonist
0,108  0,037  NADH dehydrogenase inhibitor
0,182  0,112  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,075  0,005  Catechol O-methyltransferase inhibitor
0,109  0,039  Actinic keratosis treatment
0,159  0,090  Tumour necrosis factor antagonist
0,117  0,048  Urease inhibitor
0,178  0,110  Antineoplastic enhancer
0,101  0,034  Granulocyte macrophage colony stimulating factor agonist
0,089  0,022  Biliverdin reductase inhibitor
0,117  0,051  Electron transport complex I inhibitor
0,079  0,012  Beta 2 adrenoreceptor antagonist
0,087  0,021  Antidote, heavy metal
0,176  0,111  Antiviral (Ebola)
0,106  0,042  Androgen antagonist
0,069  0,004  Sodium/glucose cotransporter 2 inhibitor
0,078  0,014  Postcoital contraceptive
0,091  0,028  Dopamine D1 antagonist
0,089  0,026  MAP kinase kinase 7 inhibitor
0,077  0,014  Oleamide hydrolase inhibitor
0,219  0,156  Antineoplastic (osteosarcoma)
0,128  0,065  Cathepsin H inhibitor
0,135  0,072  Psychosexual dysfunction treatment
0,152  0,089  Muscle relaxant
0,090  0,027  Antidote, organophosphates
0,139  0,076  Skeletal muscle relaxant
0,067  0,005  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,121  0,059  Caspase 3 inhibitor
0,111  0,049  Antineoplastic, alkylator
0,141  0,079  Antianemic
0,066  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,174  0,114  Antialcoholic
0,200  0,141  Antiischemic
0,062  0,004  Sodium/glucose cotransporter inhibitor
0,139  0,082  Thiol protease inhibitor
0,063  0,006  Sodium-dependent vitamin C transporter 2 inhibitor
0,089  0,032  Sphingosine 1-phosphate receptor antagonist
0,094  0,037  Nicotinic alpha4beta2 receptor antagonist
0,122  0,066  Adenylate cyclase inhibitor
0,113  0,056  Expectorant
0,061  0,005  Cholesterol absorption inhibitor
0,066  0,010  Dopamine beta hydroxylase inhibitor
0,141  0,085  Diuretic
0,072  0,016  Nicotinic alpha3beta2 receptor antagonist
0,070  0,014  5-Alpha-reductase inhibitor
0,071  0,015  Prolyl endopeptidase inhibitor
0,087  0,032  Carbonic anhydrase VA inhibitor
0,081  0,026  Glutamate (mGluR7) antagonist
0,060  0,006  Leukotriene C4 antagonist
0,064  0,010  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,075  0,022  NMDA 2A receptor antagonist
0,108  0,055  Adenylate kinase inhibitor
0,062  0,009  Prostacyclin antagonist
0,108  0,055  Bronchodilator
0,070  0,017  Dihydroorotate oxidase inhibitor
0,129  0,077  Interleukin 1 antagonist
0,113  0,061  Acetylcholine release stimulant
0,055  0,004  Sodium/glucose cotransporter 1 inhibitor
0,105  0,054  Sphingomyelinase inhibitor
0,094  0,043  Hematopoietic
0,058  0,007  Heme oxygenase inhibitor
0,088  0,038  Glutamate dehydrogenase inhibitor
0,116  0,066  Interleukin 8 antagonist
0,182  0,132  DNA damaging
0,065  0,016  Immunoglobulin Fc receptor antagonist
0,101  0,052  Uric acid excretion stimulant
0,069  0,019  Aconitate hydratase inhibitor
0,106  0,058  Gastric antisecretory
0,093  0,044  Inducible nitric-oxide synthase inhibitor
0,073  0,025  Postmenopausal disorders treatment
0,052  0,004  Glutamate (mGluR3) agonist
0,120  0,073  DNA repair enzyme inhibitor
0,080  0,034  Peroxisome proliferator-activated receptor gamma antagonist
0,081  0,035  Carbonic anhydrase V inhibitor
0,117  0,071  Alcohol dehydrogenase substrate
0,148  0,103  Aldehyde oxidase substrate
0,064  0,018  CD45 antagonist
0,058  0,012  Dihydropteroate synthase inhibitor
0,073  0,028  Argininosuccinate synthase inhibitor
0,099  0,055  Falcipain inhibitor
0,143  0,100  Interleukin 6 antagonist
0,172  0,128  Antineoplastic (non-small cell lung cancer)
0,205  0,161  Antineoplastic (brain cancer)
0,115  0,072  Acetylcholine muscarinic antagonist
0,097  0,054  Falcipain 2 inhibitor
0,101  0,058  Nitric-oxide synthase inhibitor
0,056  0,013  Glutamate (mGluR group II) agonist
0,074  0,032  Carbamoyl phosphate synthetase inhibitor
0,053  0,011  Glutamate (mGluR3) antagonist
0,237  0,196  Antiparkinsonian
0,060  0,019  Glucose-6-phosphate isomerase inhibitor
0,053  0,013  Beta adrenoreceptor agonist
0,115  0,074  Carcinogenic, group 3
0,082  0,042  Cathepsin G inhibitor
0,152  0,112  Phobic disorders treatment
0,044  0,005  Leukotriene B4 receptor 2 antagonist
0,085  0,045  Interferon agonist
0,072  0,033  Aromatase inhibitor
0,048  0,009  ATP citrate lysase inhibitor
0,186  0,147  5 Hydroxytryptamine 1E antagonist
0,069  0,031  Transcription factor RelA inhibitor
0,167  0,129  Platelet antagonist
0,081  0,043  NAT1 substrate
0,113  0,075  Antineoplastic antimetabolite
0,110  0,073  Microtubule formation inhibitor
0,067  0,030  Carbonic anhydrase VB inhibitor
0,084  0,047  Na+ K+ transporting ATPase inhibitor
0,050  0,014  Glutamate (mGluR2) agonist
0,118  0,082  Tubulin antagonist
0,063  0,026  Sigma receptor antagonist
0,057  0,021  NMDA receptor subunit 3B antagonist
0,051  0,015  Sphingosine kinase 1 inhibitor
0,075  0,039  Potassium channel large-conductance Ca-activated activator
0,119  0,083  Antibacterial (Helicobacter pylori)
0,059  0,024  Vanilloid 2 antagonist
0,096  0,061  Lanosterol 14 alpha demethylase inhibitor
0,053  0,018  Sphingosine 1-phosphate receptor 1 agonist
0,046  0,011  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,062  0,028  5 Hydroxytryptamine 7 agonist
0,071  0,036  Protease 3C (Human rhinovirus) inhibitor
0,043  0,009  Estrogen-related receptor beta antagonist
0,038  0,006  Prostaglandin F2 alpha agonist
0,045  0,013  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,054  0,022  Sphingosine 1-phosphate receptor agonist
0,058  0,026  Glucose-6-phosphate translocase inhibitor
0,046  0,014  Glutamate (mGluR8) agonist
0,070  0,038  Uterine relaxant
0,038  0,007  Thyroid hormone agonist
0,070  0,039  Glutamate (mGluR6) antagonist
0,063  0,032  Fatty acid synthase inhibitor
0,036  0,005  Vanilloid 2 agonist
0,045  0,015  Sirtuin 2 inhibitor
0,113  0,083  Antiviral (Influenza B)
0,066  0,036  Prostaglandin EP2 antagonist
0,178  0,149  Huntington's disease treatment
0,049  0,020  NMDA receptor subunit 3A antagonist
0,036  0,007  Estrogen-related receptor gamma antagonist
0,070  0,041  Potassium channel (ATP-sensitive) blocker
0,094  0,066  Interleukin 1 beta converting enzyme inhibitor
0,056  0,028  Anesthetic inhalation
0,106  0,078  Antitussive
0,132  0,104  Prostatic (benign) hyperplasia treatment
0,082  0,054  Glycine receptor antagonist
0,115  0,087  Retinoprotector
0,063  0,035  Heat shock protein 90 beta antagonist
0,068  0,040  Aryl hydrocarbon receptor antagonist
0,037  0,010  Thiazolidinedione
0,043  0,015  Peroxisome proliferator-activated receptor delta agonist
0,057  0,030  Thromboxane A2 antagonist
0,067  0,040  Neuraminidase (influenza) inhibitor
0,064  0,038  Beta tubulin antagonist
0,058  0,032  Epithelial sodium channel blocker
0,107  0,082  Antiprotozoal (Babesia)
0,030  0,004  Estrogen-related receptor gamma agonist
0,093  0,068  Phosphodiesterase 6D inhibitor
0,049  0,024  Oxytocin agonist
0,046  0,022  Plasmepsin II inhibitor
0,050  0,026  Phosphate transporter inhibitor
0,053  0,029  Plasminogen activator inhibitor antagonist
0,209  0,185  Antiprotozoal (Plasmodium)
0,046  0,023  Liver X receptor alpha agonist
0,044  0,021  GABA uptake inhibitor
0,062  0,039  Acetylcholine M3 receptor antagonist
0,057  0,033  Alpha tubulin antagonist
0,028  0,005  Nicotinic acid receptor 1 antagonist
0,053  0,030  Lysophosphatidic acid 3 receptor antagonist
0,053  0,030  Carbonic anhydrase XIV inhibitor
0,105  0,082  Alkylator
0,037  0,015  Calcium-independent phospholipase A2 inhibitor
0,097  0,074  Toll-Like receptor 4 antagonist
0,083  0,060  Histamine H2 receptor antagonist
0,057  0,035  Thromboxane antagonist
0,051  0,030  Adenosine deaminase inhibitor
0,071  0,050  NMDA 2 receptor antagonist
0,193  0,172  Antiallergic
0,055  0,034  Alpha-mannosidase inhibitor
0,096  0,076  AMP-activated protein kinase stimulant
0,047  0,026  AICAR transformylase inhibitor
0,024  0,004  Calcium-dependent phospholipase A2 inhibitor
0,067  0,047  Sphingosine 1-phosphate receptor 4 agonist
0,140  0,120  3C-like protease (Human coronavirus) inhibitor
0,089  0,070  Antiviral (Rhinovirus)
0,043  0,024  Kainate receptor agonist
0,033  0,015  Sigma 2 receptor antagonist
0,059  0,041  Ryanodine receptor antagonist
0,142  0,124  Antiviral (Influenza)
0,046  0,030  Mannosidase inhibitor
0,070  0,054  Histone deacetylase SIRT1 stimulant
0,070  0,054  Histone deacetylase stimulant
0,037  0,021  Fumarate hydratase inhibitor
0,090  0,074  Electrolyte absorption antagonist
0,054  0,039  Glucosylceramidase inhibitor
0,048  0,033  Cholesterol esterase inhibitor
0,222  0,208  Transcription factor inhibitor
0,055  0,040  Sphingosine 1-phosphate receptor 1 antagonist
0,092  0,078  Gout treatment
0,028  0,015  Nicotinic acid receptor 2 antagonist
0,037  0,024  Nicotinic acid receptor agonist
0,083  0,070  Tocolytic
0,025  0,012  Beta 1 adrenoreceptor agonist
0,102  0,089  Neutropenia treatment
0,081  0,068  Opioid antagonist
0,052  0,040  Ribonucleoside-diphosphate reductase inhibitor
0,103  0,091  Cholinergic antagonist
0,058  0,046  Neuraminidase inhibitor
0,025  0,013  Peroxisome proliferator-activated receptor alpha antagonist
0,043  0,032  Geranyltranstransferase inhibitor
0,037  0,026  Histone deacetylase 7 inhibitor
0,029  0,018  Sigma 1 receptor antagonist
0,034  0,023  Free fatty acid receptor 1 antagonist
0,052  0,041  Acyl-CoA dehydrogenase inhibitor
0,088  0,077  Interleukin 12 antagonist
0,051  0,041  Ribonucleotide reductase inhibitor
0,075  0,065  Opioid kappa receptor antagonist
0,074  0,064  Chymotrypsin inhibitor
0,019  0,010  Vesicular glutamate transport inhibitor
0,101  0,091  Acetylcholine antagonist
0,033  0,023  Liver X receptor beta agonist
0,164  0,155  5 Hydroxytryptamine 3E antagonist
0,015  0,006  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,020  0,011  Antibiotic Anthracycline-like
0,022  0,013  Neuraminidase (Influenza B) inhibitor
0,047  0,039  Bombesin 2 receptor antagonist
0,018  0,009  Thyroid hormone alpha agonist
0,038  0,030  Histone deacetylase 9 inhibitor
0,042  0,034  Glutamate (mGluR4) antagonist
0,030  0,022  Lysophosphatidic acid 2 receptor antagonist
0,117  0,111  Antiviral (Influenza A)
0,106  0,100  Renal failure treatment
0,034  0,028  Ceramide glucosyltransferase inhibitor
0,029  0,023  Prostaglandin agonist
0,040  0,034  Guanylate cyclase inhibitor
0,031  0,025  GABA transporter 3 inhibitor
0,094  0,089  Protein kinase C gamma inhibitor
0,041  0,036  Glutamate (mGluR group III) antagonist
0,050  0,045  Heparanase inhibitor
0,054  0,049  Pregnane X receptor antagonist
0,064  0,060  Catalase inhibitor
0,158  0,153  Myocardial infarction treatment
0,072  0,067  Antitreponemal
0,027  0,022  Liver X receptor beta antagonist
0,040  0,036  Neurotensin receptor antagonist
0,031  0,027  Peroxisome proliferator-activated receptor delta antagonist
0,032  0,029  Arginase inhibitor
0,082  0,078  Thioredoxin inhibitor
0,166  0,163  Antineoplastic (pancreatic cancer)
0,128  0,126  Sedative
0,072  0,070  Phosphodiesterase IV inhibitor
0,041  0,039  Carbonic anhydrase VII inhibitor
0,053  0,051  Opioid delta receptor antagonist
0,125  0,124  Aldose reductase substrate
0,047  0,045  5 Hydroxytryptamine 4 antagonist
0,174  0,173  Neuropeptide Y2 antagonist
0,035  0,034  Vesicle monoamine transporter inhibitor
0,029  0,027  Nucleoside transporters inhibitor
0,008  0,007  Thyroid hormone beta agonist
0,050  0,050  Cathepsin L inhibitor
0,034  0,034  Glutamate (mGluR group II) antagonist
0,067  0,067  Antineoplastic antibiotic
0,038  0,038  Nicotinic receptor alpha3 subunit antagonist

